OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Repurposing drugs against Alzheimer’s disease: can the anti-multiple sclerosis drug fingolimod (FTY720) effectively tackle inflammation processes in AD?
Volkmar Leßmann, Georgia-Ioanna Kartalou, Thomas Endres, et al.
Journal of Neural Transmission (2023) Vol. 130, Iss. 8, pp. 1003-1012
Open Access | Times Cited: 10

Showing 10 citing articles:

Repurposing Drugs: A Promising Therapeutic Approach against Alzheimer’s Disease
Swagata Pattanaik, Aruna Ghose, Kakarla Pakeeraiah, et al.
Ageing Research Reviews (2025), pp. 102698-102698
Closed Access

In-vivo neuronal dysfunction by Aβ and tau overlaps with brain-wide inflammatory mechanisms in Alzheimer’s disease
Lazaro M. Sanchez-Rodriguez, Ahmed Faraz Khan, Quadri Adewale, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 3

Molecular and neuroimmune pharmacology of S1P receptor modulators and other disease-modifying therapies for multiple sclerosis
Yasuyuki Kihara, Jerold Chun
Pharmacology & Therapeutics (2023) Vol. 246, pp. 108432-108432
Open Access | Times Cited: 5

Sphingosine 1‐phosphate signaling axis mediates neuropeptide S‐induced invasive phenotype of endometriotic cells
Matteo Prisinzano, Caterina Bernacchioni, Isabelle Seidita, et al.
FEBS Journal (2024) Vol. 291, Iss. 8, pp. 1744-1758
Closed Access | Times Cited: 1

Fingolimod alleviates type 2 diabetes associated cognitive decline by regulating autophagy and neuronal apoptosis via AMPK/mTOR pathway
Jie Li, Ming‐Jie Yin, Zhen Wang, et al.
Brain Research (2024), pp. 149241-149241
Closed Access | Times Cited: 1

Carboxylic Acid-Containing Indanyl Compounds as S1P5 Modulators for Treating Neurodegenerative Diseases
Ram W. Sabnis, Anika R. Sabnis
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 8, pp. 1033-1034
Open Access | Times Cited: 2

Learning CNS immunopathology from therapeutic interventions
Nicholas Schwab, Heinz Wiendl
Science Translational Medicine (2023) Vol. 15, Iss. 721
Closed Access | Times Cited: 2

Novel Compounds as S1P5 Modulators for Treating Neurodegenerative Diseases
Ram W. Sabnis, Anika R. Sabnis
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 6, pp. 750-751
Open Access

Transcriptomic signatures of Aβ- and tau-induced neuronal dysfunction reveal inflammatory processes at the core of Alzheimer’s disease pathophysiology
Lazaro M. Sanchez-Rodriguez, Ahmed Faraz Khan, Quadri Adewale, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access

Page 1

Scroll to top